Introduction
Hypereosinophilic Syndrome - Overview
Hypereosinophilic Syndrome - Therapeutics Development
Hypereosinophilic Syndrome - Therapeutics Assessment
Hypereosinophilic Syndrome - Companies Involved in Therapeutics Development
Hypereosinophilic Syndrome - Drug Profiles
Hypereosinophilic Syndrome - Dormant Projects
Hypereosinophilic Syndrome - Discontinued Products
Hypereosinophilic Syndrome - Product Development Milestones
Appendix

List of Tables
Number of Products under Development for Hypereosinophilic Syndrome, 2021
Number of Products under Development by Companies, 2021
Products under Development by Companies, 2021
Number of Products by Stage and Target, 2021
Number of Products by Stage and Mechanism of Action, 2021
Number of Products by Stage and Route of Administration, 2021
Number of Products by Stage and Molecule Type, 2021
Hypereosinophilic Syndrome - Pipeline by A. Menarini Industrie Farmaceutiche Riunite Srl, 2021
Hypereosinophilic Syndrome - Pipeline by GlaxoSmithKline Plc, 2021
Hypereosinophilic Syndrome - Pipeline by Incyte Corp, 2021
Hypereosinophilic Syndrome - Pipeline by Knopp Biosciences LLC, 2021
Hypereosinophilic Syndrome - Pipeline by Kyowa Kirin Co Ltd, 2021
Hypereosinophilic Syndrome - Pipeline by Nexeos Bio, 2021
Hypereosinophilic Syndrome - Dormant Projects, 2021

List of Figures
Number of Products under Development for Hypereosinophilic Syndrome, 2021
Number of Products under Development by Companies, 2021
Number of Products by Top 10 Targets, 2021
Number of Products by Stage and Top 10 Targets, 2021
Number of Products by Mechanism of Actions, 2021
Number of Products by Stage and Mechanism of Actions, 2021
Number of Products by Routes of Administration, 2021
Number of Products by Stage and Routes of Administration, 2021
Number of Products by Molecule Types, 2021
Number of Products by Stage and Molecule Types, 2021

Companies Mentioned
• A. Menarini Industrie Farmaceutiche Riunite Srl
• GlaxoSmithKline Plc
• Incyte Corp
• Knopp Biosciences LLC
• Kyowa Kirin Co Ltd
• Nexeos Bio